期刊文献+

MicroRNA-10b对人低转移肺癌细胞株95-C增殖和侵袭的作用及其机制的研究 被引量:3

Effect and mechanism of miRNA-10b on proliferation and invasion of low metastasis of lung cancer cell line 95-C
下载PDF
导出
摘要 目的微小RNA(microRNA,miRNA)-10b被证实可促进多种肿瘤细胞的生长及增强其侵袭能力。文中旨在研究miRNA-10b对人低转移肺癌细胞95-C的增殖及侵袭力的影响及其作用机制。方法用脂质体法将miRNA-10b真核表达质粒瞬时转染入95-C,实验设置空白对照组、阴性对照组和miRNA-10b质粒转染组,实时定量荧光PCR(Real-Time PCR,RT-PCR,)检测各组细胞miRNA-10b的表达及KLF4mRNA的表达,细胞增殖实验检测各组细胞的增殖情况,Transwell实验检测各组细胞侵袭能力,Western blot检测各组细胞KLF4蛋白的表达。结果转染后48h,RT-PCR检测,miRNA-10b质粒转染组miRNA-10b表达(1.61±0.12)较空白对照组(1.01±0.08)、阴性对照组(0.86±0.07)明显上调(P<0.05),阴性对照组与空白对照组差异无统计学意义(P>0.05)。生长曲线反映miRNA-10b质粒转染组细胞生长速度明显高于空白对照组和阴性对照组,差异有统计学意义(P<0.05),空白对照组和阴性对照组比较,差异无统计学意义(P>0.05);Transwell结果显示,miRNA-10b质粒转染组[(188.0±15.1)/高倍显微镜]较空白对照组[(151.0±11.3)/高倍显微镜]、阴性对照组[(136.0±10.8)/高倍显微镜]有更多的细胞迁移到Transwell膜的另一侧(P<0.05),空白对照组与阴性对照组差异无统计学意义(P>0.05);转染后48 h,miRNA-10b质粒组KLF4蛋白表达(0.86±0.06)较空白对照组(1.48±0.05)和阴性对照组(1.54±0.08)降低(P<0.05);各组细胞KLF4 mRNA表达差异无统计学意义(P>0.05)。结论 miRNA-10b可能过下调KLF4蛋白的表达促进95-C细胞的增殖及侵袭能力。 Objective MiRNA-10b is an important member of the MiRNA family , which has been proven that miRNA-10b can promote the growth and invasion of a variety of tumor cells .The aim of this study was to to investigate the effect and mechanism of miR-NA-10b on proliferation and invasion of low metastasis of lung cancer cell line (95-C). Methods The recombinant of miRNA-10b was transfected into 95-C by lipofectin method .The experiment set up 3 groups:blank control group , negative control group and miRNA-10b expression plasmid transfected group .MiRNA-10b expression level and KLF4mRNA expression level were detected by real-time fluores-cence quantitative PCR ( RTFQ-PCR) .The cell proliferation was detected by cell proliferation assay .The invasive ability of cell was de-tected by Transwell experiment .The expression of KLF4 protein was assessed by Western blot . Results At 48 hours after transfection, compared with blank control group (1.01 ±0.08) and negative control group (0.86 ±0.07), the miRNA-10b expression level in miRNA-10b expression plasmid transfected group (1.61 ±0.12) increased significantly (P〈0.05) and there was no statistical difference between blank control group and negative control group (P〉0.05).From the growth curve, the cell proliferation rate was obviously increased in miRNA-10b expression plasmid transfected group ([188.0 ±15.1]/HP) compared with the other two groups ([151.0 ±11.3]/HP), ([136.0 ±10.8]/HP) (P 〈0.05) and there was no statistical difference between these two groups ( P 〉0.05 ).Transwell result showed more cells transferred to the other side of Transwell compared with the other two groups ( P 〈0.05 ) and there was no statistical difference between these two groups (P 〉0.05).The expression of KLF4 protein decreased in miRNA-10b expression plasmid transfected group compared with the other two groups ( P〈0.05).KLF4mRNA expression decreased, but the difference had no statistical significance (P〉0.05). Conclusion MiRNA-10b might promote the pro-liferation and invasion of 95-C through down-regulation of KLF4 protein expression .
出处 《医学研究生学报》 CAS 北大核心 2014年第9期928-931,共4页 Journal of Medical Postgraduates
基金 新疆医科大学科研创新基金(XJC201156)
关键词 MicroRNA-10b 95-C KLF4 细胞增殖 侵袭能力 MicroRNA-10 b 95-C KLF4 Proliferation Invasion
  • 相关文献

参考文献15

  • 1Berezikov E, Guryev V, van de Belt J, et al. Phylogenetic shad- owing and computational identification of human microRNA genes [J]. Cell, 2005, 120(1) : 21-24.
  • 2程文,高建平,张征宇.微小RNA与肿瘤相关性研究[J].医学研究生学报,2011,24(2):203-207. 被引量:34
  • 3印洁,李玉枫,宋勇,姚鸣,高云,孙倍成,施毅.miR-21在肺癌血管生成中的作用及培美曲塞对其影响[J].医学研究生学报,2012,25(5):476-480. 被引量:8
  • 4Roth C, Kasimir-Bauer S, Pantel K, et al. Screening for circu- lating nucleic acids and caspase activity in the peripheral blood as potential diagnostic tools in lung cancer[ J]. Mol Oncol, 2011,5 (3) : 281-291.
  • 5Mehzer PS. Cancer genomics: small RNAs with big impacts[ J]. Nature, 2005, 435 (7043) : 745-746.
  • 6Yekta S, Shih IH, Barrel DP. MicroRNA-directed cleavage of HOXB8 mRNA [ J]. Science, 2004, 304 (5670) : 594- 596.
  • 7封冰,陈龙邦.微小RNA与表观遗传调控:肿瘤治疗新策略[J].医学研究生学报,2011,24(1):92-95. 被引量:20
  • 8Ya-Ching L, Chen YJ. Oncogenic function and early detection potential of miRNA-10b in oral cancer as identified by microRNA profiling[ J ]. Cancer Prey Res, 2012, 5 (4) : 665-674.
  • 9Kim K, Lee HC, Park JL, et al. Epigenetic regulation of mi- croRNA-10b and targeting of oncogenic MAPRE1 in gastric Canc- er[J]. Epigenetics, 2011, 6(6) : 740-751.
  • 10Lund E, Gtittinger S, Calado A, et al. Nuclear export of microR- NA precursors [ J]. Science, 2004, 303 (5654) : 95-98.

二级参考文献98

  • 1Tuddenham L,Wheeler G,Ntounia-Fousara S,et al.The cartilage specific microRNA-140 targets histone deacetylase 4 in mouse cells[J].FEBS Lett,2006,580(17):4214-4217.
  • 2Noonan EJ,Place RF,Pookot D,et al.miRNA-449a targets HDAC-1 and induces growth arrest in prostate cancer[J].Oncogene,2009,28(14):1714-1724.
  • 3Friedman JM,Liang G,Liu CC,et al.The putative tumor suppressor micro-RNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2[J].Cancer Res,2009,69(6):2623-2629.
  • 4Lee KH,Lotterman C,Karikari C,et al.Epigenetic silencing of MicroRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer[J].Pancreatology,2009,9(3):293-301.
  • 5Saito Y,Friedman JM,Chihara Y,et al.Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells[J].Biochem Biophys Res Commun,2009,379(3):726-731.
  • 6Mack GS.Epigenetic cancer therapy makes headway[J].J Natl Cancer Inst,2006,98(20):1443-1444.
  • 7Balch C,Fang F,Matei DE,et al.Minireview:epigenetic changes in ovarian cancer[J].Endocrinology,2009,150(9):4003-4011.
  • 8Kumar MS,Erkeland SJ,Pester RE,et al.Suppression of nonsmall cell lung tumor development by the let-7 microRNA family[J].Proc Natl Acad Sci USA,2008,105(10):3903-3908.
  • 9Takahashi Y,Forrest ARR,Maeno E,et al.MiR-107 and MiR-185 can induce cell cycle arrest in human non small cell lung cancer cell lines[J].PLoS ONE,2009,4(8):e6677.
  • 10Bartel DP.MicroRNAs:genomics,biogenesis,mechanism,and function[J].Cell,2004,116(2):281-297.

共引文献62

同被引文献21

  • 1Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015[J]. CA Cancer J Clin, 2015, 65(1): 5-29.
  • 2Marx V. Tracking metastasis and tricking cancer[J]. Nature, 2013, 494(7435): 133-138.
  • 3Hirsch FR, Bunn PA. Epidermal growth factor receptor inhibitors in lung cancer: smaller or larger molecules, selected or unselected populations?[J] J Clin Oncol, 2005, 23(36): 9044-9047.
  • 4Paez JG, Jnne PA, Lee JC, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy[J]. Science, 2004, 304(5676): 1497-1500.
  • 5Rosell R, Bivona TG, Karachaliou N. Genetics and biomarkers in personalisation of lung cancer treatment[J]. Lancet, 2013, 382(9893): 720-731.
  • 6Miyata T, Ohnishi H, Suzuki J, et al. Involvement of syntaxin 4 in the transport of membrane-type 1 matrix metalloproteinase to the plasma membrane in human gastric epithelial cells[J]. Biochem Biophys Res Commun, 2004, 323(1): 118-124.
  • 7Kean MJ, Williams KC, Skalski M, et al. VAMP3, syntaxin-13 and SNAP23 are involved in secretion of matrix metalloproteinases, degradation of the extracellular matrix and cell invasion[J]. J Cell Sci, 2009, 122(22): 4089-4098.
  • 8Suh YH, Terashima A, Petralia RS, et al. A neuronal role for SNAP-23 in postsynaptic glutamate receptor trafficking[J]. Nat Neurosci, 2010, 13(3): 338-343.
  • 9Holt M, Varoqueaux F, Wiederhold K, et al. Identification of SNAP-47, a novel Qbc-SNARE with ubiquitous expression[J]. J Biol Chem, 2006, 281(25): 17076-17083.
  • 10Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2ΔΔCT method[J]. Methods, 2001, 25(4): 402-408.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部